Insiders Johnson & Johnson Buenos Aires S.E.

Equities

End-of-day quote Buenos Aires S.E. Other stock markets 06:00:00 2024-07-14 pm EDT			5-day change	1st Jan Change
13,000 ^ARS	-9.25%		-3.33%	+28.27%

11:14am	EQT Unit Invests in Biotechnology Company Asceneuron	MT
Jul. 15	Equity Markets Higher After Fed Chair Powell's Comments	MT

Valneva Names New Chief Scientific Officer	May. 21	MT
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	Apr. 16	MT
Clearside Biomedical Names Victor Chong Chief Medical Officer	Mar. 18	MT
Johnson & Johnson Insider Sold Shares Worth $1,441,765, According to a Recent SEC Filing	Mar. 13	MT
LivaNova Names Vladimir Makatsaria as Chief Executive	Feb. 05	MT
Joseph Wolk, CFO of J&J: End of patent for its flagship drug	Jan. 23	MT
Johnson & Johnson Names Eugene Woods as Board Member	Nov. 30	DJ
Johnson & Johnson Appoints Eugene A. Woods to its Board of Directors	Nov. 30	CI
Johnson & Johnson Announces Executive Changes	23-10-23	CI
Biomea Fusion Names Juan Pablo Frias as Chief Medical Officer, Steve Morris to Become Chief Development Officer	23-08-31	MT
Top Stories at Midday: Yellow Calls it Quits; JNJ Unit Loses Second Bid at Bankruptcy; JB Hunt Buys Nikola Trucks, Walmart Raises Flipkart Stake	23-07-31	MT
Insider Sell: Johnson & Johnson	23-07-27	MT
Insider Sell: Johnson & Johnson	23-07-27	MT
INTERVIEW - Joseph Wolk, Johnson & Johnson: inflation law may hamper innovation	23-07-20	MT
Idorsia's Commercial Chief to Step Down	23-05-30	MT
Nyxoah Appoints Chief Commercial Officer	23-05-11	MT
Johnson & Johnson Announces the Retirement of Ian E. L. Davis as Director	23-04-03	CI
STAAR Surgical Appoints Warren Foust as Chief Operating Officer	23-03-29	MT
Insider Sell: Johnson & Johnson	23-03-08	MT
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to Its Board of Directors	23-02-14	CI

No results for this search

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST